ArticleScientific reports2023

An interaction-based drug discovery screen explains known SARS-CoV-2 inhibitors and predicts new compound scaffolds.

Philipp Schake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.